News
09-08-2011, 01:10 AM
Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) - the disappearance of all evidence of disease from the breast tissue and lymph nodes - regardless of disease stage after standard neoadjuvent chemotherapy, according to new research from The University of Texas MD Anderson Cancer Center...
More... (http://www.medicalnewstoday.com/releases/233986.php)
More... (http://www.medicalnewstoday.com/releases/233986.php)